Shitanshu Uppal
Landoni Trial: Radical Surgery versus Radiotherapy for Stage Ib-IIa Cervical Cancer
There is no clear treatment of choice for early-stage cervical carcinoma in terms of overall or disease-free survival. Treatment should be tailored to individual patient factors such as menopausal status, age, medical conditions, histological type, and cervical diameter to achieve the best outcomes
Publications Update # 60
PARP inhibitors in ovarian cancer and recent withdrawals, Current FDA indications, Platinum resistant ovarian cancer management, SIENDO trial
Early Stage Cervical Cancer
CONCERV Trial
Conservative surgery is feasible for select patients with early-stage, low-risk cervical cancer